Cysteamine Bitartrate
Spezifikationen
27761-19-9CAS-Nummer
248-641-7EG-Nummer
2-aminoethanethiol;(2R,3R)-2,3-dihydroxybutanedioic acidIUPAC-Name
C6H13NO6SChemische Formel
227.24 g/molMolekulargewicht
Procysbi; CYSTEAMINE BITARTRATE; 27761-19-9; Mercamine bitartrate; Mercaptamine bitartrate; QO84GZ3TST; Mercaptoethylamine bitartrate; RP-103; DTXSID801026168; beta-Mercaptoethylamine hydrogen tartrate; CHEBI:50386; Tartrate, Cysteamine; Bitartrate, Cysteamine; RefChem:54919; Cysteamine Tartrate (1:1); DTXCID501510427; 248-641-7; Cysteamine Tartrate; Ethanethiol, 2-amino-, (2R,3R)-2,3-dihydroxybutanedioate (1:1); 2-aminoethanethiol;(2R,3R)-2,3-dihydroxybutanedioic acid; Cysteamine bitartrate (JAN); 2-Aminoethanethiol (2R,3R)-2,3-dihydroxysuccinate; CYSTEAMINE BITARTRATE [JAN]; C6H13NO6S; Cystagon (TN); Procysbi (TN); UNII-QO84GZ3TST; CYSTEAMINEBITARTRATE; CHEMBL1200577; beta-Mercaptoethylamine bitartrate; CYSTEAMINE BITARTRATE [MI]; RP103; EINECS 248-641-7; CYSTEAMINE BITARTRATE [VANDF]; MFCD08277629; AKOS032954217; MERCAPTAMINE BITARTRATE [MART.]; MERCAPTAMINE BITARTRATE [WHO-DD]; CYSTEAMINE BITARTRATE [ORANGE BOOK]; D10468; E83656; Ethanethiol, 2-amino-, tartrate (1:1) (salt); .BETA.-MERCAPTOETHYLAMINE HYDROGEN TARTRATESynonyme
Produkte, die Cysteamine Bitartrate enthalten
PROCYSBI 75 MG CAPSULAS DURAS GASTRORRESISTENTESPROCYSBI 25 MG CAPSULAS DURAS GASTRORRESISTENTESPROCYSBI 75 mg, gélule gastro-résistantePROCYSBI 25 mg, gélule gastro-résistanteCYSTAGON 50 mg, géluleCYSTAGON 150 mg, géluleCysteamine Bitartrate - RecordatiCysteamine Bitartrate - Biophore India Pharmaceuticals Pvt LtdCysteamine Bitartrate - AxploraCysteamine Bitartrate - Transo-Pharm Handels GmbHCysteamine Bitartrate - Lupin Manufacturing SolutionsCysteamine Bitartrate - Cambrex Corporation
Seite 1 von 2
Unternehmen, die Cysteamine Bitartrate verkaufen
ML
MSN LaboratoriesIndia
CF
Chiesi FarmaceuticiUnited States
Seite 1 von 2